Terms: = Head and neck cancer AND EP300, ENSG00000100393, 2033, RP1-85F18_1, p300 AND Treatment
48 results:
1. Evolutionary trajectories of small cell lung cancer under therapy.
George J; Maas L; Abedpour N; Cartolano M; Kaiser L; Fischer RN; Scheel AH; Weber JP; Hellmich M; Bosco G; Volz C; Mueller C; Dahmen I; John F; Alves CP; Werr L; Panse JP; Kirschner M; Engel-Riedel W; Jürgens J; Stoelben E; Brockmann M; Grau S; Sebastian M; Stratmann JA; Kern J; Hummel HD; Hegedüs B; Schuler M; Plönes T; Aigner C; Elter T; Toepelt K; Ko YD; Kurz S; Grohé C; Serke M; Höpker K; Hagmeyer L; Doerr F; Hekmath K; Strapatsas J; Kambartel KO; Chakupurakal G; Busch A; Bauernfeind FG; Griesinger F; Luers A; Dirks W; Wiewrodt R; Luecke A; Rodermann E; Diel A; Hagen V; Severin K; Ullrich RT; Reinhardt HC; Quaas A; Bogus M; Courts C; Nürnberg P; Becker K; Achter V; Büttner R; Wolf J; Peifer M; Thomas RK
Nature; 2024 Mar; 627(8005):880-889. PubMed ID: 38480884
[TBL] [Abstract] [Full Text] [Related]
2. CDK12 alterations and ARID1A mutations are predictors of poor prognosis and therapeutic targets in high-grade salivary gland carcinoma: analysis of the National Genomic Profiling Database.
Kobayashi K; Saito Y; Kage H; Fukuoka O; Yamamura K; Mukai T; Oda K; Yamasoba T
Jpn J Clin Oncol; 2023 Aug; 53(9):798-807. PubMed ID: 37357968
[TBL] [Abstract] [Full Text] [Related]
3. [Knockdown of ACC1 promotes migration of esophageal cancer cell].
Qian H; Gu CW; Liu YZ; Zhao BS
Zhonghua Zhong Liu Za Zhi; 2023 Jun; 45(6):482-489. PubMed ID: 37355466
[No Abstract] [Full Text] [Related]
4. Prolonged Survival of NUT Midline Carcinoma and Current Approaches to treatment.
Kaplan HG; Subramaniam S; Vallières E; Barnett T
Oncologist; 2023 Sep; 28(9):765-770. PubMed ID: 37311046
[TBL] [Abstract] [Full Text] [Related]
5. An integrative approach toward identification and analysis of therapeutic targets involved in HPV pathogenesis with a focus on carcinomas.
Gupta AK; Kumar M
Cancer Biomark; 2023; 36(1):31-52. PubMed ID: 36245368
[TBL] [Abstract] [Full Text] [Related]
6. Inhibition of histone acetyltransferase function radiosensitizes CREBBP/ep300 mutants via repression of homologous recombination, potentially targeting a gain of function.
Kumar M; Molkentine D; Molkentine J; Bridges K; Xie T; Yang L; Hefner A; Gao M; Bahri R; Dhawan A; Frederick MJ; Seth S; Abdelhakiem M; Beadle BM; Johnson F; Wang J; Shen L; Heffernan T; Sheth A; Ferris RL; Myers JN; Pickering CR; Skinner HD
Nat Commun; 2021 Nov; 12(1):6340. PubMed ID: 34732714
[TBL] [Abstract] [Full Text] [Related]
7. Investigating the response scale of the EORTC QLQ-C30 in German cancer patients and a population survey.
Koller M; Müller K; Nolte S; Schmidt H; Harvey C; Mölle U; Boehm A; Engeler D; Metzger J; Sztankay M; Holzner B; Groenvold M; Kuliś D; Bottomley A;
Health Qual Life Outcomes; 2021 Oct; 19(1):235. PubMed ID: 34625074
[TBL] [Abstract] [Full Text] [Related]
8. Somatic mutations in oral squamous cell carcinomas in 98 Japanese patients and their clinical implications.
Osawa Y; Aoyama KI; Hosomichi K; Uchibori M; Tajima A; Kimura M; Ota Y
Cancer Treat Res Commun; 2021; 29():100456. PubMed ID: 34563788
[TBL] [Abstract] [Full Text] [Related]
9. Olaparib enhances curcumin-mediated apoptosis in oral cancer cells by inducing PARP trapping through modulation of BER and chromatin assembly.
Molla S; Chatterjee S; Sethy C; Sinha S; Kundu CN
DNA Repair (Amst); 2021 Sep; 105():103157. PubMed ID: 34144488
[TBL] [Abstract] [Full Text] [Related]
10. Identification of novel biomarkers and small-molecule compounds for nasopharyngeal carcinoma with metastasis.
Mi JL; Xu M; Liu C; Wang RS
Medicine (Baltimore); 2020 Aug; 99(32):e21505. PubMed ID: 32769887
[TBL] [Abstract] [Full Text] [Related]
11. In silico analysis reveals ep300 as a pancancer inhibitor of anti-tumor immune response via metabolic modulation.
Krupar R; Watermann C; Idel C; Ribbat-Idel J; Offermann A; Pasternack H; Kirfel J; Sikora AG; Perner S
Sci Rep; 2020 Jun; 10(1):9389. PubMed ID: 32523042
[TBL] [Abstract] [Full Text] [Related]
12. Efficacy of chemoradiotherapy combined with bevacizumab in patients with nasopharyngeal carcinoma: A comparative study.
Zhang F; Yuan T; Gao M
J BUON; 2019; 24(3):1252-1258. PubMed ID: 31424687
[TBL] [Abstract] [Full Text] [Related]
13. Radiotherapy versus transoral robotic surgery and neck dissection for oropharyngeal squamous cell carcinoma (ORATOR): an open-label, phase 2, randomised trial.
Nichols AC; Theurer J; Prisman E; Read N; Berthelet E; Tran E; Fung K; de Almeida JR; Bayley A; Goldstein DP; Hier M; Sultanem K; Richardson K; Mlynarek A; Krishnan S; Le H; Yoo J; MacNeil SD; Winquist E; Hammond JA; Venkatesan V; Kuruvilla S; Warner A; Mitchell S; Chen J; Corsten M; Johnson-Obaseki S; Eapen L; Odell M; Parker C; Wehrli B; Kwan K; Palma DA
Lancet Oncol; 2019 Oct; 20(10):1349-1359. PubMed ID: 31416685
[TBL] [Abstract] [Full Text] [Related]
14. Garcinol inhibits esophageal cancer metastasis by suppressing the p300 and TGF-β1 signaling pathways.
Wang J; Wu M; Zheng D; Zhang H; Lv Y; Zhang L; Tan HS; Zhou H; Lao YZ; Xu HX
Acta Pharmacol Sin; 2020 Jan; 41(1):82-92. PubMed ID: 31371781
[TBL] [Abstract] [Full Text] [Related]
15. Risk of malignancy and neoplasia predicted by three molecular testing platforms in indeterminate thyroid nodules on fine-needle aspiration.
Partyka KL; Trevino K; Randolph ML; Cramer H; Wu HH
Diagn Cytopathol; 2019 Sep; 47(9):853-862. PubMed ID: 31245935
[TBL] [Abstract] [Full Text] [Related]
16. Activin A regulates the epidermal growth factor receptor promoter by activating the PI3K/SP1 pathway in oral squamous cell carcinoma cells.
Tsai CN; Tsai CL; Yi JS; Kao HK; Huang Y; Wang CI; Lee YS; Chang KP
Sci Rep; 2019 Mar; 9(1):5197. PubMed ID: 30914776
[TBL] [Abstract] [Full Text] [Related]
17. Regulation of miRNA Biogenesis and Histone Modification by K63-Polyubiquitinated DDX17 Controls cancer Stem-like Features.
Kao SH; Cheng WC; Wang YT; Wu HT; Yeh HY; Chen YJ; Tsai MH; Wu KJ
Cancer Res; 2019 May; 79(10):2549-2563. PubMed ID: 30877109
[TBL] [Abstract] [Full Text] [Related]
18. Identification of candidate aberrantly methylated and differentially expressed genes in thyroid cancer.
Tu Y; Fan G; Xi H; Zeng T; Sun H; Cai X; Kong W
J Cell Biochem; 2018 Nov; 119(11):8797-8806. PubMed ID: 30069928
[TBL] [Abstract] [Full Text] [Related]
19. Apigenin inhibits C5a-induced proliferation of human nasopharyngeal carcinoma cells through down-regulation of C5aR.
Zhang Y; Cao Y; Zhang L; Feng C; Zhou G; Wen G
Biosci Rep; 2018 May; 38(3):. PubMed ID: 29685955
[TBL] [Abstract] [Full Text] [Related]
20. Targeted next generation sequencing identified clinically actionable mutations in patients with esophageal sarcomatoid carcinoma.
Lu H; Yang S; Zhu H; Tong X; Xie F; Qin J; Han N; Wu X; Fan Y; Shao YW; Mao W
BMC Cancer; 2018 Mar; 18(1):251. PubMed ID: 29506494
[TBL] [Abstract] [Full Text] [Related]
[Next]
